↑ Grab this Headline Animator

Research and Markets Main Indication for Interferon Beta is Multiple...

May 5, 2005 -- Research and Markets (http://www.researchandmarkets.com/reports/c16753) has announced the addition of Interferon Current Market Dynamics & Future Outlook to their offering.



At the end of 2004 the world market for Interferon was valued at $5.9 billion, a growth of 13% over 2003. The market has been growing at an average annual growth rate of 17% over the previous 5 years.



The interferon market is application driven and clearly demarcated along the lines of the type of the interferon molecule. At 60% share, interferon Beta accounts for the main bulk of the market followed by interferon Alfa at 37% market share.



Interferon alfa therapy is used as a frontline treatment for a number of indications including the treatment of malignant melanoma, hairy cell leukemia, chronic hepatitis B, chronic hepatitis C, condylomata acuminata, follicular (non-Hodgkin's) lymphoma, and AIDS-related Kaposi's sarcoma



Worldwide, 350 million people are thought to be chronically infected with HBV, a highly infectious pathogen that is responsible for an estimated 1 million deaths annually and more than 170 million people are infected with HCV with 3 to 4 million new cases occurring each year.



The main indication for interferon beta is Multiple Sclerosis (MS), a disease of the central nervous system (CNS), affecting over 400,000 people in the US and 1.2 million in the developed world.



Interferon - Current Market Dynamics & Future Outlook is a timely strategic consulting report assessing both the technology status and the competitive landscape of Interferon Alfa, Beta & Gamma and their application areas.



The report profiles leading products and companies and offers revenue forecasts to the year 2010.



Contents contained inside this report include the following:

Executive Briefing

State of the Science

Overview

Historical Perspectives

Structure, Production & Function

Interferon Alfa

Interferon Beta

Interferon Gamma

Market Size & Growth Rates

The World Market for Interferon    
   
   
   


The World Market for Interferon Alfa

The World Market for Interferon Beta

The World Market for Interferon Gamma

Companies & Products

Interferon Alfa

Roche

Pegasys

Roferon A

Schering Plough

Peg-Intron

Intron A

Other Companies on the Market

Sumitomo

Takeda

GSK

Hemispheric

Potential New Entrants into the Market

GeneMedix

Novartis / Sandoz

Ratiopharm / BioGeneriX

Interferon Beta

Biogen Idec

Avonex

Serono

Rebif

Schering Ag / Berlex   
   


Betaseron / Betaferon

Future Market

Interferon Alfa Market Forecast

Interferon Beta Market Forecast

Total Interferon Market Forecast



For more information visit http://www.researchandmarkets.com/reports/c16753



Laura Wood

Senior Manager

Research and Markets

e-mail protected from spam bots

Fax: +353 1 4100 980

↑ Grab this Headline Animator

---

This article has been robotically scanned and tagged by Prnewsnow with the following search tags. No human manipulation of these tags take place.
| Clubmom | Partners Offer | |

---

4888 readers online...

, Local News